Heteromerization, Biased Agonism, and Allosteric Modulation of G Protein‐Coupled Receptors in Addiction: Mechanistic Insights and Therapeutic Implications

Documenti analoghi

• Pharmacokinetics of Fipaxalparant, a Small‐Molecule Selective Negative Allosteric Modulator of Lysophosphatidic Acid Receptor 1, and the Effect of Food in Healthy Volunteers
  di: Yang Song, et al.
  Pubblicazione: (2024)
• Therapeutic Potential of 6‐Gingerol in Glioma: Mechanistic Insights and Experimental Validation
  di: Shan Miao, et al.
  Pubblicazione: (2025)
• The Pathway to Proof‐of‐Concept for BNC210, a Negative Allosteric Modulator of the Alpha‐7 Nicotinic Acetylcholine Receptor (nAChR), for Treatment of Psychiatric Disease
  di: Paul Rolan, et al.
  Pubblicazione: (2025)
• Structure‐Guided Design and Mechanistic Elucidation of New Chromene Derivatives as Selective Vascular Endothelial Growth Factor Receptor‐2 Inhibitors With Potent Anticancer Activity
  di: Hazem Elkady, et al.
  Pubblicazione: (2026)
• Thiazole‐Semicarbazone Hybrids as Dual‐Stage Inhibitors of Leishmania major Growth: Design, Synthesis, and Mechanistic Insights
  di: Moataz A. Shaldam, et al.
  Pubblicazione: (2026)